KLOMEN (KLOMIFEN SITRAT) 50 MG 30 TB KOCAK FARMA KOCAK

£106.00

Klomifen sitrat (clomiphene citrate) is a selective estrogen receptor modulator manufactured by Kocak Farma for laboratory research applications investigating hormonal pathway mechanisms.

 

  • 30 days easy returns
  • Order yours before 2.30pm for same day dispatch
KLOMEN (KLOMIFEN SITRAT) 50 MG 30 TB KOCAK FARMA KOCAK
KLOMEN (KLOMIFEN SITRAT) 50 MG 30 TB KOCAK FARMA KOCAK
£106.00

[wpforms id=”1190″ title=”true” description=”Request a call back”]

Compound Overview and Laboratory Research Applications

Klomifen sitrat (clomiphene citrate) is a non-steroidal selective estrogen receptor modulator (SERM) manufactured by Kocak Farma in 50mg tablet formulation. Researchers at Stroid UK Shop study this compound for its selective antagonist properties at hypothalamic estrogen receptors, which modulate gonadotropin release pathways in preclinical models. The compound demonstrates tissue-selective activity, functioning as an estrogen antagonist in certain tissues while exhibiting agonist properties in others, making it valuable for comprehensive endocrine research protocols.

Molecular Mechanisms in Research Models

Laboratory studies examine how clomiphene citrate competitively binds to estrogen receptors, particularly investigating its effects on hypothalamic-pituitary-gonadal axis function. Researchers within our post cycle therapy research collection analyse the compound’s ability to block negative feedback mechanisms typically mediated by estrogen. The molecular formula C₂₆H₂₈ClNO with molecular weight 405.96 g/mol allows for precise analytical quantification in research applications. Scientists investigate the differential binding affinities and tissue-specific responses that characterise SERM compounds in various experimental protocols.

Research Integration with Other Compounds

Advanced research protocols often examine clomiphene citrate alongside other investigational compounds. Scientists studying recovery mechanisms frequently analyse this compound in conjunction with selective androgen receptor modulators to understand comprehensive hormonal pathway interactions. Research laboratories also investigate synergistic effects when studying clomiphene citrate with peptide compounds that modulate growth hormone pathways. These multi-compound research approaches provide insights into complex endocrine system interactions and recovery mechanisms in controlled laboratory environments.

Product Specifications and Research Compliance

Klomifen Sitrat Research Specifications
Parameter Specification
Active Compound Clomiphene Citrate
Strength 50mg per tablet
Quantity 30 tablets
Manufacturer Kocak Farma
CAS Number 50-41-9
Storage Requirements Room temperature, dry environment

This product is manufactured exclusively for in-vitro laboratory research purposes. Not approved for human consumption, therapeutic use, or any application outside controlled research environments. Researchers must possess appropriate credentials and facilities for handling research chemicals safely and in compliance with applicable regulations.

Related